Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Biogen Inc. (BIIB)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS)
All
(14)
DE
(5)
AR
(1)
AT
(1)
CH
(1)
CL
(1)
MX
(1)
IT
(2)
GB
(1)
US
(1)
NASDAQ (NGS)
Primary
LSE
XMIL
XWBO
XSGO
BCBA
XMEX
XFRA
XHAN
XMUN
XSTU
XDUS
XMIL
SIX
$
235.
35
+2.52
+1.0823%
$
33.35B
Market Cap
24.69
P/E Ratio
-
Div Yield
1.57M
Volume
14.99
Eps
$
232.83
Previous Close
Investors:
TJD
LC
BZ
ABB
+241
Analysts:
Watching
Watch
Add Transaction
Day Range
235.22
240.99
Year Range
138
240.99
Want to track
BIIB
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Analysts
Biogen Inc. (BIIB) Statistics
Valuation metrics
Market Cap
33.35B
Enterprise value
40.42B
Trailing P/E (ttm)
39.74
Forward P/E
11.63
PEG ratio
-0.87
Price/Sales (ttm)
3.35
Price/Book (mrq)
1.77
Enterprise Value/Revenue
4.06
Enterprise Value/EBITDA
20.67
Overview
Shares outstanding
147.6M
Float
147.18M
Shares short
4.48M
% Held by insiders
0%
% Held by institutions
0.96%
Average volume (10 days)
815K
Average volume (90 days)
1.1M
Price summary
52-Week low
138
52-Week high
240.99
Beta
0.2
50-Day moving average
219.75
200-Day moving average
194.57
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
1 Feb 2017
Ex-Dividend Date
2 Feb 2017
Last split factor
3:1
Last split Date
18 Jan 2001
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.08%
Operating margin
0.13%
Operational effectiveness
Return on assets
0.03%
Return on equity
0.05%
Income Statement
Revenue (ttm)
9.94B
Revenue per share (ttm)
67.35
Quarterly revenue growth (yoy)
0.02%
Gross profit (ttm)
7.82B
EBITDA
3.27B
Net income to common (ttm)
1.37B
Diluted EPS (ttm)
5.65
Quarterly earnings growth (yoy)
0.33%
Balance Sheet
Total cash (mrq)
4.28B
Total cash per share (mrq)
8.7
Total debt (mrq)
6.56B
Total Debt/Equity (mrq)
0.44
Current ratio (mrq)
1.87%
Book value per share (mrq)
127.61
Cash Flow
Cash flow statement
2.59B
Levered free cash flow (LFCF)
1.92B